Proinflammatory CD14(+)CD16(+) monocytes are associated with vascular stiffness in predialysis patients with chronic

Jae-Won Lee1, Eunjung Cho1, Myung-Gyu Kim1

  • 1Division of Nephrology, Department of Internal Medicine, Korea University, Anam Hospital, Seoul, Korea.

Insights

The proinflammatory CD14(+)CD16(+) monocyte subset expands in chronic kidney disease (CKD) patients, correlating with inflammation and cardiovascular risks. This expansion contributes to inflammation, malnutrition, and atherosclerosis in CKD.

Area of Science:

  • Immunology
  • Nephrology
  • Cardiology

Background:

  • Chronic inflammation is a hallmark of chronic kidney disease (CKD), exacerbating cardiovascular disease (CVD) risk.
  • Monocytes, key immune cells, exist in subtypes including proinflammatory CD14(+)CD16(+) cells.
  • The role of monocyte subset expansion in predialysis CKD pathogenesis is unclear.

Purpose of the Study:

  • To investigate the expansion of proinflammatory CD14(+)CD16(+) monocytes in predialysis CKD patients.
  • To determine associations between this monocyte subset expansion and systemic inflammation markers.
  • To explore correlations with cardiovascular risk factors in CKD.

Main Methods:

  • Flow cytometry was used to quantify CD14(+)CD16(+) monocyte percentages in 111 predialysis CKD patients.
  • Analysis included comparisons with brachial-ankle pulse wave velocity (baPWV), plasma cytokine levels, and clinical parameters.

Main Results:

  • CD14(+)CD16(+) monocyte proportion was higher in advanced CKD stages and correlated with elevated Interleukin-6.
  • Monocyte expansion positively correlated with high-sensitive C-reactive protein and negatively with albumin, hemoglobin, and 25(OH)-vitamin D.
  • Expansion of CD14(+)CD16(+) monocytes independently predicted baPWV in diabetic CKD patients.

Conclusions:

  • Expansion of proinflammatory CD14(+)CD16(+) monocytes is a significant finding in predialysis CKD.
  • This monocyte subset expansion contributes to chronic inflammation, malnutrition, and atherosclerosis in CKD patients.
  • Targeting this monocyte subset may offer therapeutic potential for managing CKD complications.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
927
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.8K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.1K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
469
Inflammatory Response I: Vascular and Cellular01:30

Inflammatory Response I: Vascular and Cellular

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
18.3K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
593